speaker-icon

Latest Posts

Innoplexus-AIO-partnership

2

Jan 24

Innoplexus and AIO Studien gGmbH are jointly announcing the start of a pilot project as part of the AIO data hub initiative

January 02, 2024 - Innoplexus and Amrit AG, members of the Partex NV Group, providers of innovative technology for health...
Read More
anavex_partex_partnership_Innoplexus

27

Jun 23

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Category: Press release 2019

catana-pr

Catana Capital: New collaboration with Life Science AI pioneer Innoplexus

Catana Capital partners with a leading provider of AI solutions in the Life Science sector Frankfurt am Main, December 16, 2019: As a pioneer in the application of Big Data and AI for quantitative asset management, Catana Capital is always open to collaborate with other innovators in the space in order to develop new innovative investment …

Catana Capital: New collaboration with Life Science AI pioneer Innoplexus Read More »

Innoplexus-and-Wiley-partnership

Innoplexus and Wiley partner to provide AI-powered solutions over comprehensive research literature

Frankfurt, Germany, October 15, 2019 – Innoplexus AG announces a partnership with John Wiley & Sons, Inc. (NYSE: JW-A) (NYSE: JW-B) to enable Innoplexus’s proprietary, ontology-driven search and artificial intelligence-powered analysis on the full text of life science articles published by Wiley, one of the largest scientific and scholarly publishing houses in the world. This …

Innoplexus and Wiley partner to provide AI-powered solutions over comprehensive research literature Read More »

Cutting-Edge-Chemistry

Innoplexus and ChemAxon partner to get more out of life science data

Frankfurt, Germany – Budapest, Hungary, September 16, 2019 – Innoplexus announces an official partnership with ChemAxon, getting the most value out from life sciences data. Through the joint venture, Innoplexus will enable big pharma and biotech companies to find and connect information about pharmaceutical compounds from publicly available, or archived enterprise datasets to generate novel …

Innoplexus and ChemAxon partner to get more out of life science data Read More »

New Employee Joining

Innoplexus Announces Appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President

Hoboken, New Jersey, September 16, 2019- Innoplexus Inc., a subsidiary of Innoplexus AG, announced today the appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President. Mr. Davlos is a highly accomplished artificial intelligence and machine learning executive with over 20 years of leadership experience. Prior to joining Innoplexus, Mr. Davlos was …

Innoplexus Announces Appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President Read More »

New Employee Joining

Innoplexus Announces Appointment of Rita Kelley as Senior Vice President and Managing Director, USA

Hoboken, New Jersey, September 12, 2019 – Innoplexus Inc, a subsidiary of Innoplexus AG, Frankfurt, which has developed the most comprehensive, industry validated, AI-powered Drug Discovery and Development platform, announced today the appointment of Rita Kelley as Senior Vice President Corporate Development and Marketing. Rita will also act as Managing Director USA. Ms. Kelley is …

Innoplexus Announces Appointment of Rita Kelley as Senior Vice President and Managing Director, USA Read More »

Cures-Within-Reach

Innoplexus and Cures Within Reach for Cancer Tap the Power of Artificial Intelligence to Find Off-Patent Non-Cancer Drugs That Have Potential to Treat Cancer

Hoboken, NJ, August 5, 2019 – Innoplexus Holdings, Inc., a leader in artificial intelligence (AI) solutions for the life sciences industry, has partnered with the nonprofit Cures Within Reach for Cancer to pave the way for faster and more effective identification of new, affordable cancer treatments among existing non-cancer generic and off-patent drugs. Innoplexus is …

Innoplexus and Cures Within Reach for Cancer Tap the Power of Artificial Intelligence to Find Off-Patent Non-Cancer Drugs That Have Potential to Treat Cancer Read More »

Academic-Access-Program

Innoplexus Launches Worldwide Academic Access Program for its Flagship Ontosight.ai

Frankfurt, Germany, May 21, 2019 — Innoplexus announced today the launch of Ontosight Academic, a platform that provides academic researchers free access to a vast volume of life sciences data made searchable using machine learning algorithms and other artificial intelligence technologies. Today, academic researchers in life sciences are swamped with millions of publications and theses …

Innoplexus Launches Worldwide Academic Access Program for its Flagship Ontosight.ai Read More »

INNOPLEXUS-WIEDER-IM-GARTNER-HYPE-CYCLE-FÜR-LIFE-SCIENCES

INNOPLEXUS WIEDER IM GARTNER HYPE CYCLE FÜR LIFE SCIENCES

Eschborn, Januar 2019. Das weltweit angesehene US-Analystenhaus Gartner Inc. veröffentlicht jährlich seinen Hype Cycle für Life Sciences, um Unternehmensvorstände zu unterstützen, neue Technologien zu verstehen, Investments zu priorisieren und Organisationen neuen Anforderungen anzupassen. Das zweite Jahr in Folge wurde die Innoplexus AG, ein führender europäischer Anbieter von Künstlicher Intelligenz (KI), im Report der Analysten genannt. …

INNOPLEXUS WIEDER IM GARTNER HYPE CYCLE FÜR LIFE SCIENCES Read More »